ABVX

10.55

2.73% 0.28

アフターアワーズ： 10.55

Abivax Adr (ABVX)

概要ニュース株価時系列ディスカッション予測

前日終値:

$10.27

開ける：

$10.41

24時間の取引高:

33,187

Relative Volume:

0.28

時価総額：

$654.34M

収益：

当期純損益:

$-159.39M

株価収益率:

EPS:

ネットキャッシュフロー:

$-105.22M

1週間パフォーマンス:

-1.31%

1か月パフォーマンス:

+7.87%

6か月パフォーマンス:

-27.44%

1年パフォーマンス:

+4.46%

1日の値動き範囲:

$10.25

$11.02

1週間の範囲:

$10.21

$11.02

52週間の値動き範囲:

$8.75

$17.02

Abivax Adr Stock (ABVX) Company Profile

名前

Abivax Adr

セクター

Healthcare (1180)

産業

Biotechnology (680)

電話

住所

職員

Twitter

次回の収益日

2024-11-07

最新のSEC提出書

ABVX's Discussions on Twitter

Abivax Adr Stock (ABVX) Upgrades & Downgrades

日付	アクション	アナリスト	評価の変更
2023-11-14	開始されました	Leerink Partners	Outperform
2023-11-14	開始されました	Morgan Stanley	Equal-Weight

Abivax Adr (ABVX) 最新ニュース

Oct 15, 2024

Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News

Oct 15, 2024

Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex

Oct 15, 2024

Oct 07, 2024

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.

Oct 07, 2024

Sep 26, 2024

Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN

Sep 14, 2024

Sep 13, 2024

Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Sep 13, 2024

Sep 09, 2024

Abivax SA Details Financial Struggles and Advances - TipRanks

Sep 09, 2024

Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks

Sep 09, 2024

Jul 15, 2024

Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.

Jul 15, 2024

Jun 04, 2024

Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks

Jun 04, 2024

May 07, 2024

Abivax SA Announces Upcoming General MeetingTipRanks.com - TipRanks

May 07, 2024

Apr 29, 2024

Guggenheim starts Abivax stock with Buy, cites promising ulcerative colitis drug By Investing.com - Investing.com

Apr 29, 2024

Apr 02, 2024

Abivax SA Secures Funding and Expands Operations - TipRanks

Apr 02, 2024

Oct 26, 2023

Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire

Oct 26, 2023

Abivax Adr (ABVX) 財務データ

収益

当期純利益

現金流量

EPS

SMMT

$19.96

5.11%

INCY

$75.75

0.50%

UTHR

$376.80

0.74%

MRNA

$53.54

2.00%

BGNE

$207.25

1.49%

BNTX

$108.97

2.25%

Abivax Adr (ABVX)

Abivax Adr Stock (ABVX) Company Profile

Abivax Adr Stock (ABVX) Upgrades & Downgrades

Abivax Adr (ABVX) 最新ニュース

Check Out Abivax ADR (ABVX)’s Trade Data Rather Than the Analysts’ Views - SETE News

Insider’s View: Deciphering Abivax ADR (ABVX)’s Financial Health Through Ratios - The Dwinnex

Abivax Congratulates Victor Ambros and Gary Ruvkun on Their Nobel Prize for the Discovery of microRNA and its Role in Post-Transcriptional Gene Regulation - GlobeNewswire Inc.

Abivax SA Unveils New Ulcerative Colitis Treatment Data - TipRanks

Abivax Reports Progress in Ulcerative Colitis Therapy - TipRanks

DEADLINE ALERT for ABR, FIVE, DXC, and INDV: The Law - GlobeNewswire

Wall Street Analysts Believe Abivax SA Sponsored ADR (ABVX) Could Rally 193.62%: Here's is How to Trade - MSN

Is Abivax SA Sponsored ADR (ABVX) Outperforming Other Medical Stocks This Year? - Yahoo Finance

Abivax SA Details Financial Struggles and Advances - TipRanks

Abivax SA Reveals Soaring R&D Costs in H1 2024 - TipRanks

Inflammatory Bowel Disease Treatment Market Size Expected to Reach USD 33.19 Bn by 2032 - GlobeNewswire Inc.

Abivax SA Advances with Positive Trial OutcomesTipRanks.com - TipRanks

Abivax SA Announces Upcoming General MeetingTipRanks.com - TipRanks

Guggenheim starts Abivax stock with Buy, cites promising ulcerative colitis drug By Investing.com - Investing.com

Abivax SA Secures Funding and Expands Operations - TipRanks

Citi Appointed as Depositary Bank for Abivax SA's ADR Program - Business Wire

Abivax Adr (ABVX) 財務データ

収益

当期純利益

現金流量

EPS

ABVXに似た銘柄